http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2360682-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9ea47a4d0d0067db3ec642e553905144
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9715ee42ca04792255166d73b4f79385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d40960190e37af1e3390c21a67554f98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f9a49cc756dd5fcac2b9ace52f42c7e1
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-24
filingDate 2007-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2009-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_646cca1b32347c88489c3883cc02d398
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3cf5358fcc39562c383d81fecee4ae07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd92ae3cdbd3ac252a9a7e5c5a6a846d
publicationDate 2009-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2360682-C1
titleOfInvention Therapy of bone metastases in breast cancer
abstract FIELD: medicine. n SUBSTANCE: invention refers to medicine, namely to oncology, and can be used in therapy of breast cancer with bone metastasis. Substance of the invention consists in puncture with a needle between III and IV lumbar vertebras in subarachnoid spinal marrow space. Cerebrospinal fluid in amount 2 ml is poured in a sterile bottle and added with Epitalamine 10 mg. The bottle is incubated in a thermostat at temperature 37°C within 20 minutes. Then the prepared mixed liquor and Epitalamine are introduced back into subarachnoid space that is combined with introduction of hydrocortisone 125 mg. The therapeutic course includes 4 lumbal punctures with introduction of preparations once a week. n EFFECT: application of the invention provides regress of bone metastases, reduced toxic collateral reactions of hormonotherapy, immune correction ensured by combined endoliquor introduction of said agents. n 2 ex
priorityDate 2007-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416060312
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5754
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491841
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID688058
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9294
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419477255

Total number of triples: 28.